LEUCEMIA LINFOCÍTICA CRÓNICA B (LLC-B): DETECCIÓN TRISOMÍA CROMOSOMA 12 - CIDEGEN
CIDEGEN
Delivery time
<1 week
Sample
Blood. Biopsy tissue. Bone marrow
166,98€
Trisomy 12. Intermediate risk in B-cell chronic lymphocytic leukemia (15-20%). Marker of intermediate prognosis. Therapy with Bruton's tyrosine kinase inhibitors.